Candel Therapeutics Files 8-K
Ticker: CADL · Form: 8-K · Filed: Dec 5, 2025 · CIK: 1841387
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Candel Therapeutics filed an 8-K on 12/5/25 for Reg FD disclosure and exhibits.
AI Summary
Candel Therapeutics, Inc. filed an 8-K on December 5, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific details about the nature of the disclosure or the financial statements.
Why It Matters
This filing indicates Candel Therapeutics is making a regulatory disclosure and submitting financial documents, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, with no immediate indication of significant negative events.
Key Players & Entities
- Candel Therapeutics, Inc. (company) — Registrant
- December 5, 2025 (date) — Date of Report
- 117 Kendrick St., Suite 450 Needham, MA 02494 (address) — Principal Executive Offices
FAQ
What specific information is being disclosed under Regulation FD?
The filing does not specify the content of the Regulation FD disclosure.
What types of financial statements and exhibits are included in this filing?
The filing indicates that financial statements and exhibits are included, but does not detail their specific nature.
Has Candel Therapeutics, Inc. undergone any name changes recently?
The filing notes a former name change date of 20210120, but does not indicate any recent changes.
What is the Commission File Number for Candel Therapeutics, Inc.?
The Commission File Number is 001-40629.
What is the IRS Employer Identification Number for Candel Therapeutics, Inc.?
The IRS Employer Identification Number is 52-2214851.
Filing Stats: 633 words · 3 min read · ~2 pages · Grade level 10.5 · Accepted 2025-12-05 08:30:52
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value per share CADL The Nasdaq
Filing Documents
- d43361d8k.htm (8-K) — 26KB
- d43361dex991.htm (EX-99.1) — 86KB
- g43361ex99_1p10g1.jpg (GRAPHIC) — 275KB
- g43361ex99_1p11g1.jpg (GRAPHIC) — 310KB
- g43361ex99_1p12g1.jpg (GRAPHIC) — 388KB
- g43361ex99_1p13g1.jpg (GRAPHIC) — 334KB
- g43361ex99_1p14g1.jpg (GRAPHIC) — 331KB
- g43361ex99_1p15g1.jpg (GRAPHIC) — 263KB
- g43361ex99_1p16g1.jpg (GRAPHIC) — 327KB
- g43361ex99_1p17g1.jpg (GRAPHIC) — 271KB
- g43361ex99_1p18g1.jpg (GRAPHIC) — 307KB
- g43361ex99_1p19g1.jpg (GRAPHIC) — 293KB
- g43361ex99_1p1g1.jpg (GRAPHIC) — 244KB
- g43361ex99_1p20g1.jpg (GRAPHIC) — 312KB
- g43361ex99_1p21g1.jpg (GRAPHIC) — 366KB
- g43361ex99_1p22g1.jpg (GRAPHIC) — 235KB
- g43361ex99_1p23g1.jpg (GRAPHIC) — 178KB
- g43361ex99_1p24g1.jpg (GRAPHIC) — 262KB
- g43361ex99_1p25g1.jpg (GRAPHIC) — 134KB
- g43361ex99_1p26g1.jpg (GRAPHIC) — 262KB
- g43361ex99_1p27g1.jpg (GRAPHIC) — 192KB
- g43361ex99_1p28g1.jpg (GRAPHIC) — 254KB
- g43361ex99_1p29g1.jpg (GRAPHIC) — 110KB
- g43361ex99_1p2g1.jpg (GRAPHIC) — 649KB
- g43361ex99_1p30g1.jpg (GRAPHIC) — 252KB
- g43361ex99_1p31g1.jpg (GRAPHIC) — 179KB
- g43361ex99_1p32g1.jpg (GRAPHIC) — 248KB
- g43361ex99_1p33g1.jpg (GRAPHIC) — 320KB
- g43361ex99_1p34g1.jpg (GRAPHIC) — 240KB
- g43361ex99_1p35g1.jpg (GRAPHIC) — 178KB
- g43361ex99_1p36g1.jpg (GRAPHIC) — 169KB
- g43361ex99_1p37g1.jpg (GRAPHIC) — 225KB
- g43361ex99_1p38g1.jpg (GRAPHIC) — 311KB
- g43361ex99_1p39g1.jpg (GRAPHIC) — 361KB
- g43361ex99_1p3g1.jpg (GRAPHIC) — 367KB
- g43361ex99_1p40g1.jpg (GRAPHIC) — 422KB
- g43361ex99_1p41g1.jpg (GRAPHIC) — 309KB
- g43361ex99_1p42g1.jpg (GRAPHIC) — 350KB
- g43361ex99_1p43g1.jpg (GRAPHIC) — 338KB
- g43361ex99_1p44g1.jpg (GRAPHIC) — 329KB
- g43361ex99_1p45g1.jpg (GRAPHIC) — 378KB
- g43361ex99_1p46g1.jpg (GRAPHIC) — 285KB
- g43361ex99_1p47g1.jpg (GRAPHIC) — 270KB
- g43361ex99_1p48g1.jpg (GRAPHIC) — 296KB
- g43361ex99_1p49g1.jpg (GRAPHIC) — 360KB
- g43361ex99_1p4g1.jpg (GRAPHIC) — 225KB
- g43361ex99_1p50g1.jpg (GRAPHIC) — 300KB
- g43361ex99_1p51g1.jpg (GRAPHIC) — 169KB
- g43361ex99_1p52g1.jpg (GRAPHIC) — 264KB
- g43361ex99_1p53g1.jpg (GRAPHIC) — 283KB
- g43361ex99_1p54g1.jpg (GRAPHIC) — 223KB
- g43361ex99_1p55g1.jpg (GRAPHIC) — 211KB
- g43361ex99_1p56g1.jpg (GRAPHIC) — 315KB
- g43361ex99_1p57g1.jpg (GRAPHIC) — 304KB
- g43361ex99_1p58g1.jpg (GRAPHIC) — 284KB
- g43361ex99_1p59g1.jpg (GRAPHIC) — 329KB
- g43361ex99_1p5g1.jpg (GRAPHIC) — 288KB
- g43361ex99_1p60g1.jpg (GRAPHIC) — 356KB
- g43361ex99_1p61g1.jpg (GRAPHIC) — 194KB
- g43361ex99_1p62g1.jpg (GRAPHIC) — 276KB
- g43361ex99_1p63g1.jpg (GRAPHIC) — 340KB
- g43361ex99_1p64g1.jpg (GRAPHIC) — 330KB
- g43361ex99_1p65g1.jpg (GRAPHIC) — 351KB
- g43361ex99_1p66g1.jpg (GRAPHIC) — 264KB
- g43361ex99_1p67g1.jpg (GRAPHIC) — 166KB
- g43361ex99_1p68g1.jpg (GRAPHIC) — 242KB
- g43361ex99_1p69g1.jpg (GRAPHIC) — 381KB
- g43361ex99_1p6g1.jpg (GRAPHIC) — 303KB
- g43361ex99_1p70g1.jpg (GRAPHIC) — 337KB
- g43361ex99_1p71g1.jpg (GRAPHIC) — 231KB
- g43361ex99_1p72g1.jpg (GRAPHIC) — 294KB
- g43361ex99_1p73g1.jpg (GRAPHIC) — 237KB
- g43361ex99_1p74g1.jpg (GRAPHIC) — 251KB
- g43361ex99_1p75g1.jpg (GRAPHIC) — 335KB
- g43361ex99_1p76g1.jpg (GRAPHIC) — 347KB
- g43361ex99_1p77g1.jpg (GRAPHIC) — 304KB
- g43361ex99_1p78g1.jpg (GRAPHIC) — 166KB
- g43361ex99_1p79g1.jpg (GRAPHIC) — 235KB
- g43361ex99_1p7g1.jpg (GRAPHIC) — 227KB
- g43361ex99_1p80g1.jpg (GRAPHIC) — 223KB
- g43361ex99_1p8g1.jpg (GRAPHIC) — 276KB
- g43361ex99_1p9g1.jpg (GRAPHIC) — 235KB
- 0001193125-25-308719.txt ( ) — 31364KB
- cadl-20251205.xsd (EX-101.SCH) — 3KB
- cadl-20251205_lab.xml (EX-101.LAB) — 18KB
- cadl-20251205_pre.xml (EX-101.PRE) — 11KB
- d43361d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 R&D Day Presentation dated December 5, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Candel Therapeutics, Inc. Date: December 5, 2025 By: /s/ Paul Peter Tak Paul Peter Tak, M.D., Ph.D., FMedSci President and Chief Executive Officer